HQ USAGF; EMERGENCY MEDICAL TREATMENT AT USAF

File: aabgl_01.txt
Page: 01
Total Pages: 2

SUBJECT: HQ USAGF; EMERGENCY MEDICAL TREATMENT AT USAF
CASUALTY COLLECTION POINTS

PRIORITY

UNCLASSIFIED
BASE COMMUNICATIONS CENTER
390 COSQ/DONA

PAGE 01 OF 02 18/0300Z
STRATEGIC AIR COMMAND (UNIT TOTAL: 003)
OPR: SG (03)

OPR: E B STRATEGIC HOSPITAL (04)
INFO: FILE COPY(01) COMMAND SECT COURTESY COPY (01)

------------------------ 18/0318Z A2 03 (TOTAL COPIES: 009)
PATEZYUW RUEABOL 0791 2300141- --RUCUAAA.
ZNY
P 172100Z AUG 90
FM HQ USAF BOLLING AFB DC//SG//
TO AIG 8201//SG//
RUWTENA/ 3790 MSTW SHEPPARD AFB TX// MSR//
RUVKBRK/ HO HSD BROOKS AFB TX//CC//.
RUVKBRK/USAFSAM BROOKS AFB TX //ED//
INFO RUEADWD/DA WASHINGTON DC//SGPS-PSP/DASD-HCD-D//
RULNEAA/ CDRUSAMRICD ABERDEEN PROVING GROUND MD//SGRD-UV-ZA//
ZEN BUMED WASHINGTON DC//MED-02C//
BT
UNCLAS
SUBJ: EMERGENCY MEDICAL TREATMENT AT USAF CASUALTY COLLECTION POINTS
OF OPERATION DESERT SHIELD CASUALTIES EXPOSED TO NERVE AGENTS
1. A CREDIBLE THREAT OF CHEMICAL ATTACK WITH NERVE AGENTS EXISTS IN
THE AREA OF RESPONSIBILITY (AOR) FOR OPERATION DESERT SHIELD. THE
ATTACHED GUIDANCE ON EMERGENCY MEDICAL TREATMENT AT USAF CASUALTY
COLLECTION POINTS (CCPS) HAS BEEN DEVELOPED TO MAXIMIZE THE SURVIVAL
OF OPERATION DESERT SHIELD CASUALTIES EXPOSED TO NERVE AGENTS
2. MANAGE NERVE AGENT CASUALTIES AT USAF CCPS AS FOLLOWS
2A. INSURE ALL CASUALTIES ARE WEARING THEIR CHEMICAL MASK;.
2B. TRIAGE CASUALTIES AS FOLLOWS
2B1. IMMEDIATE:
2B1. 2 CONVULSIONS
2B1. 3 LOSS OF CONSCIOUSNESS
2B1. 4 OBSTRUCTIVE AIRWAY SECRETIONS
2B1. 5 CYANOSIS
2B2. DELAYED
2B2.1 PROFUSE ORAL/PHARYNGEAL SECRETIONS WITHOUT
SIGNS OR SYMPTOMS OF AIRWAY OBSTRUCTION
2B2.2 MUSCLE TWITCHING/FASCICULATIONS WITH OR
WITHOUT WEAKNESS
2B3. MINIMAL
2B3.1 RESOLVED SYMPTOMS WITHOUT TREATMENT OR AFTER 2
MG ATROPINE (OR 1 ATROPINE [GREEN] AUTOINJECTOR) AND/OR 1
PRALIDOXIME [BLACK] AUTOINJECTOR
2B3.2 NASAL CONGESTION
2B3.3 SEVERE EYE PAIN, BLURRED OR DIM VISION
2B3.4 SEVERE RETROBULBAR HEADACHE
2B3.5 NAUSEA
2B3.6 MILD CHEST TIGHTNESS
2B4. EXPECTANT
2B4.1 CHEMICAL AGENT EXPOSURE IN A PATIENT WITH AN
2B5. IF THE TACTICAL SITUATION ALLOWS, TREAT IMMEDIATES AS
FOLLOWS:
2B5.1 ASSURE THE CASUALTY HAS RECEIVED AT LEAST 7 ML
;14 MG) OF BULK ATROPINE IM (OR 7 ATROPINE AUTOINJECTORS [GREEN]
AND 3 PRALIDOXIME [BLACK] AUTOINJECTORS
2B5.2 INJECT THE CONTENTS OF ONE (1) 10 MG PRE-
FILLED DIAZEPAM (VALIUM) SYRINGE DEEP INTO THE MID-ANTEROLATERAL
MUSCLE OF THE THIGH; IF THE CASUALTY IS CONVULSING, DOUBLE THE DOSE
2B5.3 IF THE AIRWAY APPEARS TO BE OBSTRUCTED OR THE
CASUALTY STOPS BREATHING,
2B5.3.1 REMOVE THE MASK
2B5.3.2 CLEAR THE MOUTH AND AIRWAY
2B5.3.3 INSERT AN ARTIFICIAL AIRWAY (E.G.
ORAL OR NASAL AIRWAY)
2B5.3.4. REPLACE THE CASUALTY'S MASK
2B5.4 INJECT ONE ML ATROPINE IM OR ONE ATROPINE
AUTOINJECTOR [GREEN] EVERY 5 MINUTES UNTIL BREATHING IS ADEQUATE
AND AIRWAY SECRETIONS ARE CONTROLLED. TRY TO GET THE HEART RATE

UNCLASSIFIED